Peter H. Watson
BC Cancer Agency(CA)Henry Ford Health System(US)Cancer Council Victoria(AU)University of Victoria(CA)Genome Canada(CA)Victorian Cancer Biobank(AU)Community Health Alliance(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Ethics in Clinical Research, Estrogen and related hormone effects, Immunotherapy and Immune Responses, Immune Cell Function and Interaction
Most-Cited Works
- → The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups(2012)6,273 cited
- → New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆(1999)2,500 cited
- → Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma(2011)2,021 cited
- → The clonal and mutational evolution spectrum of primary triple-negative breast cancers(2012)2,008 cited
- Hypoxia-inducible expression of tumor-associated carbonic anhydrases.(2000)
- → Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution(2009)1,074 cited
- → Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors